The growing acceptance of psychedelics as a source for treating health conditions and promoting wellbeing has led several companies and non-profit organizations worldwide to launch initiatives supporting those interested in accessing these therapies, ranging from programs on psychedelics fundamentals, clinical trial patients’ rights, peer support for specific populations and safe microdosing, to networks connecting with qualified professionals for integration therapy and promoting research and access.
